Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
24/7 Wall St
7h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Managed Healthcare Executive
11h
IBX Excludes Coverage of Drugs with Accelerated Approvals for 18 Months
Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Court rejects latest attempt
Finalize their divorce
Announces $20B investment
Laken Riley Act passed
Inmates reject clemency
Driver pleads not guilty
Pleads not guilty
Bodies found in landing gear
Antisemitic threats arrest
Biden signs RFK Stadium bill
Sanctioned for corruption?
SoCal windstorm warning
Folk legend Yarrow dies
To roll back diversity goals
Job openings rise
Raiders fire head coach
Israeli raids in West Bank
Files motion to dismiss case
US trade deficit widens
Online holiday sales rise
Judge halts report release
Tesla faces US probe
Strong earthquake hits Tibet
Labels Chinese firms
Police reform deal approved
Remains arrive in D.C.
On China's cyber activity
French far-right leader dies
Detainees moved to Oman
Draws 10.1 million viewers
To lay off 4% of staff
Related topics
Novo Nordisk
Liraglutide
Food and Drug Administration
Feedback